Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Video-Thoracoscopic Management of Postpneumonectomy Empyema
Domenico Galetta1, Lorenzo Spaggiari1,2
1Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.
Background:
Postpneumonectomy empyema (PPE) is a serious complication even when it is not associated with bronchopleural fistula (BPF). Besides irrigation, an aggressive treatment is usually applied for removing infected material. However, a minimally invasive approach might achieve satisfactory results in selected patients.
Methods:
We retrospectively identified 18 patients presenting with PPE receiving video-thoracoscopic approach. Of these 18 patients, pneumonectomy was performed for nonsmall cell lung cancer in 15 cases, for mesothelioma in 2, and for trauma in 1 case. There were 14 males and 4 females, (mean age, 62 years; range, 44-73 days). Empyema was confirmed by thoracentesis and bacteriological examination. All patients had immediate chest tube drainage and underwent thoracoscopic debridement of the empyema. Fifteen patients had no proven BPF; two had suspicious BPF, and one had a minor (<3 mm) BPF.
Results:
Median time from pneumonectomy to empyema diagnosis was 129 days (range, 7-6205 days). Median time from drain position to video-assisted thoracoscopic surgery (VATS) procedure was 10 days (range, 2-78 days). A bacterium was isolated in 13 cases (72.2%). There was no mortality and no morbidity related to the procedure. The average duration of thoracoscopic debridement was 56 minutes (range, 40-90 minutes). Median postoperative stay was 7 days (range, 6-18 days). Only in one patient an open-window thoracostomy was performed. Median follow-up of the 18 patients receiving thoracoscopy was 41.5 months (range, 1-78 months). None had recurrent empyema. The patient with a minor BPF remained asymptomatic and is doing well at 48 months follow-up.
Conclusions:
Thoracoscopy might be a valid approach for patients presenting with PPE with or without minimal BPF. Video-thoracoscopic debridement of postpneumonectomy space is an efficient method to treat PPE.
Insights
Video-thoracoscopic debridement is an effective minimally invasive treatment for postpneumonectomy empyema (PPE), even with minor bronchopleural fistulas (BPF). This approach offers a safe and efficient alternative to aggressive treatments for selected patients.
Area of Science:
- Thoracic Surgery
- Minimally Invasive Procedures
- Infectious Disease Management
Background:
- Postpneumonectomy empyema (PPE) is a severe complication following lung removal surgery.
- Traditional treatments for PPE involve aggressive irrigation and material removal.
- Minimally invasive options may offer satisfactory outcomes in select cases.
Purpose of the Study:
- To evaluate the efficacy and safety of video-thoracoscopic surgery for treating postpneumonectomy empyema.
- To assess outcomes in patients with and without bronchopleural fistula (BPF).
Main Methods:
- Retrospective review of 18 patients with PPE treated via video-thoracoscopic approach.
- All patients underwent chest tube drainage and thoracoscopic debridement.
- Patient data included pneumonectomy indication, BPF status, and procedural details.
Main Results:
- No mortality or morbidity associated with the video-thoracoscopic procedure.
- Average debridement time was 56 minutes; median postoperative stay was 7 days.
- No recurrent empyema observed during a median follow-up of 41.5 months.
Conclusions:
- Video-thoracoscopic debridement is a viable and efficient treatment for PPE.
- The approach is effective even in the presence of minimal bronchopleural fistulas.
- Minimally invasive thoracoscopy provides a safe and effective treatment option for selected PPE patients.
Related Concept Videos
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Managing Impressions
Management of Insomnia
Cystic Fibrosis: Management
Sinus disease and chronic...
Angina IV: Management

